phase 1/2 trial
Arcturus reports positive results for sa-mRNA COVID boosters in phase 1/2 trial
Anika Sharma
Amid a shrinking COVID-19 vaccine market, Arcturus Therapeutics is forging ahead with its mRNA candidate, revealing promising early data demonstrating ...
